Dr. Maky Zanganeh is a recognized leader in the healthcare industry. Dr. Zanganeh is currently the Chief Operating Officer, and member of the board at Summit Therapeutics, a company committed to the betterment of overall human health.
Dr. Zanganeh is the recipient of many awards and honors including:
• Honored Speaker at the United Nations meeting in February 2022 in conversation with His Excellency the President of the 76th Session of the United Nations General Assembly, Mr. Abdulla Shahid, Her Excellency Ms. Amal Mudallali, Ambassador and Permanent Representative of Lebanon to the United Nations and Her Excellency Ms. Sima Bahous, Executive Director, UN-Women, during the during the Esteemed Closing Ceremony.
• Honored as one of the top 10 influential Chief Operating Officers of 2021
• Earned the Fierce Biotech “2013 Top women in biotech” award, and the E&Y company “Entrepreneur of the Year” 2013 award
• Earned the E&Y company “Entrepreneur of the Year” 2013 award.
• Honored Keynote Speaker at multiple companies including Medable, an elite company named to the CNBC 2022 Disruptor List
• Board member: Pulse Biosciences
One of her greatest leadership accomplishments occurred when Dr. Zanganeh, as Chief Operating Officer at Pharmacyclics, led a struggling biotech company to a multimillion-dollar collaboration and license deal for ibrutinib with Johnson & Johnson in 2011 and the subsequent sale of the company for $21 billion for 50% ownership of ibrutnib in 2015 to AbbVie Inc. which was the second largest biopharma sale ever in the industry at that time. The deal with Johnson & Johnson received the award of the “Best Biotech Transaction” in 2011. Under her leadership in 2015, Pharmacyclics was also awarded the prestigious Prix Galien for “Best Pharmaceutical Agent”. This award is the biomedical industry’s highest accolade and recognizes outstanding achievements in the development of new therapies.
Dr. Zanganeh was President of EMEA / Global VP of Training and Education for Computer Motion, Inc. (Pioneers in Robotic Surgery) which later merged with Intuitive, Inc. (ISRG) company in June 2003. Dr. Zanganeh was awarded her DDS (Dental Degree of Surgery) from the Louis Pasteur University, France and an MBA from Schiller International University, France. She is fluent in French, German, Farsi, and English. She is also a published author, recently releasing her book entitled The Magic of Normal. Dr. Zanganeh will be holding a book signing during this event.